0001209191-19-049230.txt : 20190911 0001209191-19-049230.hdr.sgml : 20190911 20190911191815 ACCESSION NUMBER: 0001209191-19-049230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190909 FILED AS OF DATE: 20190911 DATE AS OF CHANGE: 20190911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 191089276 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-09 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001560782 Daly James M C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2019-09-09 4 M 0 30000 17.52 A 30000 D Common Stock 2019-09-09 4 S 0 29600 37.7873 D 400 D Common Stock 2019-09-09 4 S 0 400 38.39 D 0 D Stock Option (Right to Buy) 17.52 2019-09-09 4 M 0 30000 0.00 D 2028-06-05 Common Stock 30000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.33 to $38.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The option is fully vested and exercisable. /s/ Austin D. Kim, Attorney-in-Fact 2019-09-11